1. Home
  2. MDXG vs CSR Comparison

MDXG vs CSR Comparison

Compare MDXG & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • CSR
  • Stock Information
  • Founded
  • MDXG 2006
  • CSR 1970
  • Country
  • MDXG United States
  • CSR United States
  • Employees
  • MDXG N/A
  • CSR N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • CSR Real Estate Investment Trusts
  • Sector
  • MDXG Health Care
  • CSR Real Estate
  • Exchange
  • MDXG Nasdaq
  • CSR Nasdaq
  • Market Cap
  • MDXG 1.0B
  • CSR 1.0B
  • IPO Year
  • MDXG N/A
  • CSR N/A
  • Fundamental
  • Price
  • MDXG $7.25
  • CSR $61.39
  • Analyst Decision
  • MDXG Strong Buy
  • CSR Buy
  • Analyst Count
  • MDXG 3
  • CSR 8
  • Target Price
  • MDXG $12.00
  • CSR $71.75
  • AVG Volume (30 Days)
  • MDXG 815.1K
  • CSR 101.9K
  • Earning Date
  • MDXG 04-30-2025
  • CSR 05-01-2025
  • Dividend Yield
  • MDXG N/A
  • CSR 5.02%
  • EPS Growth
  • MDXG N/A
  • CSR N/A
  • EPS
  • MDXG 0.27
  • CSR N/A
  • Revenue
  • MDXG $352,375,000.00
  • CSR $263,570,000.00
  • Revenue This Year
  • MDXG $9.23
  • CSR $4.42
  • Revenue Next Year
  • MDXG $11.49
  • CSR $3.42
  • P/E Ratio
  • MDXG $26.71
  • CSR N/A
  • Revenue Growth
  • MDXG 5.34
  • CSR 2.19
  • 52 Week Low
  • MDXG $5.47
  • CSR $54.13
  • 52 Week High
  • MDXG $10.14
  • CSR $76.16
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 54.99
  • CSR 55.31
  • Support Level
  • MDXG $6.53
  • CSR $59.51
  • Resistance Level
  • MDXG $7.52
  • CSR $61.62
  • Average True Range (ATR)
  • MDXG 0.34
  • CSR 1.79
  • MACD
  • MDXG 0.11
  • CSR 0.31
  • Stochastic Oscillator
  • MDXG 81.63
  • CSR 85.44

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About CSR D/B/A Centerspace

Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.

Share on Social Networks: